Skip to main navigation Skip to search Skip to main content

Phase II trial of gemcitabine, irinotecan, and celecoxib in patients with advanced pancreatic cancer

  • Allan Lipton
  • , Cynthia Campbell-Baird
  • , Lois Witters
  • , Harold Harvey
  • , Suhail Ali

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II trial of gemcitabine, irinotecan, and celecoxib in patients with advanced pancreatic cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology